Chicken E. coli Symptoms: Clinical Manifestations of Avian Pathogenic Escherichia coli

Introduction

Avian pathogenic Escherichia coli (APEC) constitutes a heterogeneous group of extraintestinal pathogenic E. coli (ExPEC) that cause a spectrum of clinical diseases collectively termed colibacillosis [1, 2]. Colibacillosis is one of the most economically significant bacterial diseases affecting the global poultry industry, resulting in increased morbidity, mortality, carcass condemnation, and reduced production performance [3, 1, 4]. APEC strains are not defined by a single set of virulence determinants but rather by a combination of plasmid-borne and chromosomal genes that enable colonization of the respiratory tract, systemic dissemination, and survival within host tissues [1, 5]. The clinical presentation of APEC infection ranges from acute septicemia with sudden death to localized chronic inflammatory lesions in the respiratory tract, serosal membranes, reproductive organs, skin, and umbilicus [1, 6, 7]. Understanding the clinical manifestations is essential for timely diagnosis, implementation of control measures, and differentiation from other avian pathogens such as Infectious Coryza in Poultry and Ducks or Highly Pathogenic Avian Influenza (H5N1) in Poultry.

Pathogenesis and Routes of Infection

APEC typically enters the host through the respiratory tract via inhalation of contaminated dust or aerosol droplets, especially in environments with poor ventilation and high stocking density [1, 8]. The bacteria adhere to the respiratory epithelium using fimbrial adhesins (e.g., Fim, Stg) and then invade the air sacs, lung parenchyma, and subsequently the bloodstream [2, 9]. The ability to resist complement-mediated serum killing and phagocytosis, mediated by factors such as the outer membrane protein TolA and the Iss protein, facilitates systemic spread [10, 7]. Following hematogenous dissemination, APEC colonizes internal organs including the heart, liver, spleen, and peritoneum, leading to the characteristic fibrinous polyserositis [10, 11].

Alternate routes include entry via the gastrointestinal tract, particularly in cases of co-infection with cecal parasites such as Histomonas meleagridis, which disrupts the mucosal barrier [8]. Vertical transmission through contaminated eggs and hatchery fluff can result in omphalitis in neonates [4, 75]. Additionally, skin wounds or vent trauma may allow entry leading to cellulitis [12, 90]. Stressors such as temperature fluctuations, high humidity, concurrent viral infections, and immunosuppression predispose birds to clinical disease [13, 14, 15].

Clinical Syndromes

The clinical manifestations of APEC infection are diverse and depend on the strain virulence, infectious dose, host age and immune status, and presence of concurrent infections [16, 17]. Below are the major clinical syndromes associated with avian colibacillosis.

Acute Colisepticemia

Acute septicemia is the most fulminant form, often seen in young broilers and layers within the first few weeks of life [4, 92]. Clinical signs include sudden death without premonitory symptoms, depression, ruffled feathers, anorexia, increased body temperature, and cyanosis of comb and wattles [3, 4, 18]. Mortality can reach up to 100% in extremely virulent outbreaks, especially when precipitated by respiratory viral infections [19, 18]. Moribund birds exhibit severe weakness, prostration, and diarrhea [3, 20].

Respiratory and Air Sac Infections

Respiratory involvement is common, often presenting as airsacculitis characterized by dyspnea, coughing, sneezing, and rales [13, 18]. The air sacs become thickened, opaque, and filled with caseous exudate; the lungs may show congestion and pneumonia [4, 18]. This form frequently follows primary infection with Mycoplasma gallisepticum or low pathogenic avian influenza (LPAI) H9N2 virus, which damage respiratory epithelium and impair mucociliary clearance [13, 18, 15]. Co-infection with LPAI H9N2 significantly exacerbates clinical signs and mortality compared to APEC alone [19, 18].

Fibrinous Polyserositis (Pericarditis, Perihepatitis, Peritonitis)

Subacute to chronic colibacillosis is characterized by fibrinous inflammation of serosal surfaces. Pericarditis presents as a thickened, opaque pericardium with fibrin deposition (so-called "bread and butter" heart) [4, 92]. Perihepatitis appears as a fibrinous membrane covering the liver (glissonitis), often accompanied by hepatic congestion and necrosis [3, 92]. Peritonitis involves the abdominal cavity, with fibrin plaques and caseous exudate, particularly in laying hens [21]. These lesions are indicative of systemic spread and are often observed at postmortem.

Salpingitis and Reproductive Tract Infections

In adult laying hens and breeders, APEC can cause ascending infections of the oviduct resulting in salpingitis, often observed as a drop in egg production, deformed eggs, and vent prolapse [21, 75]. Salpingitis may be acute with large accumulations of egg yolk and caseous material in the oviduct, or chronic with fibrous adhesions [21]. Gallibacterium anatis is another common cause of salpingitis, but APEC is frequently isolated concurrently.

Omphalitis (Yolk Sac Infection)

Omphalitis affects newly hatched chicks and is characterized by infection of the yolk sac and umbilicus [4, 75]. Affected chicks appear weak, lethargic, and have poor growth. The yolk sac is thickened, discolored (greenish or hemorrhagic), and contains inspissated material [4]. The navel may be moist and inflamed. This form is often associated with poor hatchery hygiene and vertical transmission [75]. Mortality peaks in the first week.

Cellulitis

Cellulitis is a localized subcutaneous infection of broilers, usually involving the abdomen and thigh areas [12, 90]. It manifests as thickened, yellowish, caseous plaques in the subcutaneous tissue that cause carcass rejection at processing [12]. Clinically, affected birds may not show obvious signs of systemic illness, but the condition results in reduced growth and feed efficiency [90]. The condition often arises from scratches or skin abrasions contaminated with litter containing APEC [12].

Swollen Head Syndrome

Swollen head syndrome is a periorbital and periocular swelling with subcutaneous edema, sometimes extending to the infraorbital sinuses [82]. It is often a multifactorial condition involving APEC in combination with respiratory viruses such as avian pneumovirus or infectious bronchitis virus [82, 85]. Affected birds exhibit dyspnea, depression, and head shaking.

Gross and Histopathological Correlates

Gross lesions vary according to syndrome. In acute septicemia, there is generalized congestion, petechiae on heart and kidney, and serosanguineous fluid in body cavities [4]. In subacute cases, fibrinous exudates on serosal membranes are pathognomonic [4, 92]. Histopathologically, APEC infection causes coagulative necrosis in liver, myocardium, and spleen, with infiltration of heterophils and macrophages [3, 11]. In the liver, fatty degeneration and necrotic foci are common; in the lung, there is interstitial pneumonia with edema and fibrin [3]. Intestinal changes include villus atrophy, epithelial necrosis, and submucosal edema [3, 4]. In Histomonas meleagridis-APEC co-infection, the cecal mucosa shows ulceration and mixed inflammatory infiltrates, and systemic bacterial translocation is enhanced [8].

Role of Virulence Factors in Symptom Manifestation

The severity and type of clinical signs are correlated with the repertoire of virulence-associated genes (VAGs) carried by the APEC strain [22, 23, 24]. Among the most important are genes encoding iron acquisition systems (iroN, iucD, sitA), which are critical for growth in the iron-limited environment of the host [25, 26, 74]. The presence of the large plasmid (ColV plasmid) carrying genes such as iss (increased serum survival), hlyF (haemolysin), ompT (outer membrane protease), and iroN is strongly associated with systemic disease [5, 74]. Strains positive for multiple VAGs are more likely to cause severe clinical forms such as septicemia and polyserositis [22, 24]. In contrast, isolates from subclinical or localized lesions (e.g., cellulitis) often harbor fewer VAGs [12, 90].

Impact of Co-infections on Clinical Presentation

Concurrent infections with other pathogens dramatically alter the clinical picture. Co-infection with Mycoplasma gallisepticum and LPAI H9N2 results in severe respiratory disease and high mortality [27, 18]. Similarly, co-infection with Histomonas meleagridis promotes cecal pathology, dysbiosis, and systemic translocation of APEC [8]. Infection with infectious bronchitis virus (IBV) enhances APEC adhesion to respiratory epithelium, leading to aggravated airsacculitis [13]. Immunosuppressive agents such as chicken anemia virus or infectious bursal disease virus increase susceptibility to APEC and severity of colibacillosis [2].

Diagnostic Considerations

Diagnosis of APEC infections is based on clinical signs, gross and histopathological lesions, and laboratory confirmation via isolation and identification of E. coli from affected tissues (liver, heart, bone marrow, etc.) [3, 92]. Molecular detection using PCR targeting specific VAGs (e.g., iroN, hlyF, iss, ompT) aids in differentiating APEC from commensal strains [23, 28, 29]. Multiplex PCR panels and loop-mediated isothermal amplification (LAMP) protocols have been developed for rapid on-site testing [23, 29]. Whole genome sequencing provides high-resolution characterization of serotypes, sequence types, and resistance determinants [30, 5, 31, 32].

Summary of Clinical Signs by Disease Form

Mermaid Diagram: Clinical Progression of APEC Infection

flowchart TD
    A["Respiratory entry: inhalation of contaminated dust"] --> B[Adherence to respiratory epithelium]
    B --> C[Invasion of air sacs and lung parenchyma]
    C --> D{Systemic dissemination via bloodstream}
    D --> E["Acute septicemia: sudden death, cyanosis"]
    D --> F["Fibrinous polyserositis: pericarditis, perihepatitis"]
    D --> G[Localized chronic forms]
    G --> H["Omphalitis: yolk sac infection"]
    G --> I["Cellulitis: subcutaneous plaques"]
    G --> J["Salpingitis: oviduct infection"]
    D --> K["Co-infections (Mycoplasma, H9N2, Histomonas") exacerbate severity]
    K --> L[Severe respiratory disease, high mortality]

References

[1] A. Watts, P. Wigley. Avian Pathogenic Escherichia coli: An Overview of Infection Biology, Antimicrobial Resistance and Vaccination. Antibiotics, 2024.

[2] Jiangang Hu et al. Characteristics, pathogenic mechanism, zoonotic potential, drug resistance, and prevention of avian pathogenic Escherichia coli (APEC). Frontiers in Microbiology, 2022.

[3] Jellia Wibisono Freshinta et al. Histopathological Diagnosis and Detection of Avian Pathogenic Escherichia Coli Virulence Genes in Broiler Chickens in Indonesia. Archives of Razi Institute, 2025.

[4] Q. A. Shah et al. AVIAN ESCHERICHIA COLI INFECTION IN MEAT-TYPE CHICKEN: PREVALENCE AND PATHOLOGY. Pakistan journal of agriculture, agricultural engineering & veterinary sciences, 2021.

[5] T. Johnson et al. Refining the definition of the avian pathogenic Escherichia coli (APEC) pathotype through inclusion of high-risk clonal groups. Poultry Science, 2022.

[6] ABUBAKAR S. M. ABBA et al. AVIAN PATHOGENIC ESCHERICHIA COLI IN DISEASED CHICKENS FROM COMMERCIAL FARMS IN NORTHWEST, NIGERIA. International Journal of Social Health and Medical Research, 2025.

[7] M. Dho-Moulin, J. Fairbrother. Avian pathogenic Escherichia coli (APEC). Veterinary Research, 1999.

[8] M. Abdelhamid et al. Co-infection of Chicken Layers With Histomonas meleagridis and Avian Pathogenic Escherichia coli Is Associated With Dysbiosis, Cecal Colonization and Translocation of the Bacteria From the Gut Lumen. Frontiers in Microbiology, 2020.

[9] Maria H. Lymberopoulos et al. Characterization of Stg Fimbriae from an Avian Pathogenic Escherichia coli O78:K80 Strain and Assessment of Their Contribution to Colonization of the Chicken Respiratory Tract. Journal of Bacteriology, 2006.

[10] Senyan Su et al. The multifaceted role of TolA protein in promoting survival, biofilm formation and virulence of avian pathogenic Escherichia coli. Poultry Science, 2024.

[11] M. Abdelhamid et al. A comprehensive study of colisepticaemia progression in layer chickens applying novel tools elucidates pathogenesis and transmission of Escherichia coli into eggs. Scientific Reports, 2024.

[12] A. Müller et al. Molecular characterization of Escherichia coli isolates recovered from broilers with cellulitis. Poultry Science, 2024.

[13] A. Saleh. Clinical Signs and Gross Lesion of Infectious Bronchitis Virus Associated with E. coli in Broiler Farm at Kirkuk City, Iraq. EAS Journal of Veterinary Medical Science, 2026.

[14] Sarah Saci et al. Epidemiological study and identification of Escherichia coli strains associated with clinical events in Avian farming. Revista Científica de la Facultad de Ciencias Veterinarias, 2024.

[15] N. Mosleh et al. Evaluation of the timing of the Escherichia coli co-infection on pathogenecity of H9N2 avian influenza virus in broiler chickens. Iranian Journal of Veterinary Research, 2017.

[16] Andreas Alber et al. Dose-dependent differential resistance of inbred chicken lines to avian pathogenic Escherichia coli challenge. Avian Pathology, 2019.

[17] S. Pors et al. Variations in virulence of avian pathogenic Escherichia coli demonstrated by the use of a new in vivo infection model. Veterinary Microbiology, 2014.

[18] S. Jaleel et al. Pathological Alterations in Respiratory System During Co-infection with Low Pathogenic Avian Influenza Virus (H9N2) and Escherichia Coli in Broiler Chickens. Journal of Veterinary Research, 2017.

[19] Sherif Mahmoud et al. Effect of Co-infection of Low Pathogenic Avian Influenza H9N2 Virus and Avian Pathogenic E. coli on H9N2-Vaccinated Commercial Broiler Chickens. Frontiers in Veterinary Science, 2022.

[20] Xia Meng et al. RyhB in Avian Pathogenic Escherichia coli Regulates the Expression of Virulence-Related Genes and Contributes to Meningitis Development in a Mouse Model. International Journal of Molecular Sciences, 2022.

[21] R. Olsen et al. Experimental induced avian E. coli salpingitis: Significant impact of strain and host factors on the clinical and pathological outcome. Veterinary Microbiology, 2016.

[22] J. Wilczyński et al. Molecular and Serological Characteristics of Avian Pathogenic Escherichia coli Isolated from Various Clinical Cases of Poultry Colibacillosis in Poland. Animals, 2022.

[23] Joanna Kazimierczak et al. A rapid detection of Avian Pathogenic Escherichia coli (APEC) strains based on minimal number of virulence markers identified by whole genome sequencing. BMC Microbiology, 2025.

[24] L. Awawdeh et al. Virulence-associated genes in faecal and clinical Escherichia coli isolates cultured from broiler chickens in Australia. Australian Veterinary Journal, 2024.

[25] Fangfang Li et al. Molecular Epidemiology and Antibiotic Resistance Associated with Avian Pathogenic Escherichia coli in Shanxi Province, China, from 2021 to 2023. Microorganisms, 2025.

[26] E. Ons et al. High prevalence iron receptor genes of avian pathogenic Escherichia coli. Avian Pathology, 2007.

[27] N. Yehia et al. Evaluation of the Effect of Co-Infection by Mycoplasma gallisepticum (Mg) and E. coli O78 on the Pathogenicity of Avian Influenza (H9N2) in the Spf Chicks. Macedonian Veterinary Review, 2026.

[28] C. Ewers et al. Rapid Detection of Virulence-Associated Genes in Avian Pathogenic Escherichia coli by Multiplex Polymerase Chain Reaction. Avian diseases, 2005.

[29] P. Kogovšek et al. Loop-mediated isothermal amplification: rapid molecular detection of virulence genes associated with avian pathogenic Escherichia coli in poultry. Poultry Science, 2018.

[30] Xuhua Chen et al. Whole genome sequencing analysis of avian pathogenic Escherichia coli from China. Veterinary Microbiology, 2021.

[31] Aneta Papoušková et al. Genomic analysis of avian-pathogenic Escherichia coli (APEC) isolated from diseased chicken. Journal, 2019.

[32] Jingyao Wang et al. Decoding the genome and epigenome of avian Escherichia coli strains by R10.4.1 nanopore sequencing. Frontiers in Veterinary Science, 2025.

[33] Siwaporn Bilhman et al. A novel lytic Seuratvirus phage CABI-SEA 2301 with broad host range against multidrug-resistant avian pathogenic Escherichia coli. The Veterinary Journal, 2025.

[34] Dossêh Jean Apôtre Afayibo et al. Isolation, Molecular Characterization, and Antibiotic Resistance of Avian Pathogenic Escherichia coli in Eastern China. Veterinary Sciences, 2022.

[35] Sina Bagheri et al. Production of interferon gamma and interleukin 17A in chicken T-cell subpopulations hallmarks the stimulation with live, irradiated and killed avian pathogenic Escherichia coli. Developmental and Comparative Immunology, 2022.

[36] Mobin Karami et al. In vitro evaluation of two novel Escherichia bacteriophages against multiple drug resistant avian pathogenic Escherichia coli. BMC Infectious Diseases, 2024.

[37] Haichang Yin et al. Butyric acid from ligilactobacillus animalis 2020MB acts on membrane BamA to control avian pathogenic escherichia coli. Poultry Science, 2025.

[38] G. Adwan et al. Molecular characterization of avian pathogenic Escherichia coli isolates from broiler farms in Northern Palestinian territories. Veterinary World, 2024.

[39] Giulia Von Tönnemann Pilati et al. Bacteriophage-Associated Antimicrobial Resistance Genes in Avian Pathogenic Escherichia coli Isolated from Brazilian Poultry. Viruses, 2023.

[40] Ting Xu et al. Isolation and therapeutic potential of phage vB_EcoM_GXW16 against a drug-resistant avian pathogenic Escherichia coli strain. Poultry Science, 2026.

[41] M. A. Saeed et al. Cross-Sectional Study for Detection and Risk Factor Analysis of ESBL-Producing Avian Pathogenic Escherichia coli Associated with Backyard Chickens in Pakistan. Antibiotics, 2023.

[42] Marianne Nicolas et al. Isolation and Characterization of a Novel Phage Collection against Avian-Pathogenic Escherichia coli. Microbiology spectrum, 2023.

[43] K. LeStrange et al. An evaluation of the virulence and adherence properties of avian pathogenic Escherichia coli. One Health, 2017.

[44] Katsunori Seki et al. Synthesis and Immunological Evaluation of Escherichia coli O1- Derived Oligosaccharide–Protein Conjugates toward Avian Pathogenic Escherichia coli O1 Vaccine Development. Synthesis, 2023.

[45] Jinwu Meng et al. The synergy effect of matrine and berberine hydrochloride on treating colibacillosis caused by an avian highly pathogenic multidrug-resistant Escherichia coli. Poultry Science, 2024.

[46] W. Fricke et al. Antimicrobial Resistance-Conferring Plasmids with Similarity to Virulence Plasmids from Avian Pathogenic Escherichia coli Strains in Salmonella enterica Serovar Kentucky Isolates from Poultry. Applied and Environmental Microbiology, 2009.

[47] Waleed Abu El Hammed et al. Isolation and Molecular Identification of Avian Pathogenic Escherichia coli in Broiler Chickens Suffering from Colibacillosis in some Governorates in Egypt. Egyptian Journal of Veterinary Sciences, 2022.

[48] Jinwu Meng et al. Bacteriostatic Effects of Yujin Powder and Its Components on Clinical Isolation of Multidrug-Resistant Avian Pathogenic Escherichia coli. Veterinary Sciences, 2023.

[49] D. Dissanayake et al. Population structure and virulence content of avian pathogenic Escherichia coli isolated from outbreaks in Sri Lanka. Veterinary Microbiology, 2014.

[50] Harold Durango et al. Evaluation of the Virulence Factor Profile of Avian Pathogenic Escherichia Coli in Clinical Isolates of Avian Samples in Caloto, Cauca, Colombia. Journal, 2021.

[51] Samina Ievy et al. Genomic characteristics, virulence and antimicrobial resistance in avian pathogenic Escherichia coli MTR_BAU02 strain isolated from layer farms in Bangladesh. Journal of Global Antimicrobial Resistance, 2022.

[52] G. Younis et al. Phenotypic and genotypic characterization of antimicrobial susceptibility of avian pathogenic Escherichia coli isolated from broiler chickens. Veterinary World, 2017.

[53] Marwa A. Nassar et al. Isolation, Characterization and Genetic Analysis of Antibiotic Resistance Genes and Virulence Factors of Escherichia Coli Isolated From Chicken Farms in Egypt. Egyptian Journal of Veterinary Sciences, 2024.

[54] L. Awawdeh et al. Antimicrobial susceptibility, plasmid replicon typing, phylogenetic grouping, and virulence potential of avian pathogenic and faecal Escherichia coli isolated from meat chickens in Australia. Avian Pathology, 2022.

[55] Esther-Maria Antão et al. The chicken as a natural model for extraintestinal infections caused by avian pathogenic Escherichia coli (APEC). Microbial Pathogenesis, 2008.

[56] J. Tu et al. The irp2 and fyuA genes in High Pathogenicity Islands are involved in the pathogenesis of infections caused by avian pathogenic Escherichia coli (APEC). Polish journal of veterinary sciences, 2016.

[57] D. Dissanayake et al. Distribution of lipopolysaccharide core types among avian pathogenic Escherichia coli in relation to the major phylogenetic groups. Veterinary Microbiology, 2008.

[58] Xiangru Wang et al. Plasmid-mediated multidrug resistance and virulence in an avian pathogenic Escherichia coli strain isolated in China. Journal of Global Antimicrobial Resistance, 2014.

[59] T. Nagano et al. An attenuated mutant of avian pathogenic Escherichia coli serovar O78: a possible live vaccine strain for prevention of avian colibacillosis. Microbiology and immunology, 2012.

[60] Xiangkun Wang et al. The role of transforming growth factor beta-1 protein in Escherichia coli secondary infection induced by H9N2 avian influenza virus in chickens. Microbial Pathogenesis, 2023.

[61] Jabbar A. A. Al-Waely. The protective role of outer membrane protein against Avian pathogenic E.coli in broilers. Journal, 2017.

[62] C. Ewers et al. Intestine and Environment of the Chicken as Reservoirs for Extraintestinal Pathogenic Escherichia coli Strains with Zoonotic Potential. Applied and Environmental Microbiology, 2008.

[63] J. Sarowska et al. Comparative Characteristics and Pathogenic Potential of Escherichia coli Isolates Originating from Poultry Farms, Retail Meat, and Human Urinary Tract Infection. Life, 2022.

[64] Aneta Papoušková et al. Genomic analysis of Escherichia coli strains isolated from diseased chicken in the Czech Republic. BMC Veterinary Research, 2019.

[65] D. G. White. Antimicrobial Resistance in Pathogenic Escherichia coli from Animals. Antimicrobial Resistance in Bacteria of Animal Origin, 2019.

[66] Roseliza Roslee et al. Phylogenetic grouping and virulence gene profiles of Escherichia coli isolated from chicken. Journal, 2017.

[67] Abdi Ahmed Umer, Ebisa Mezgebu Hambisa. Escherichia coli Isolation, Prevalence, and Multi Drug Resistance from a Poultry Farm in Sendafa Town, Central Ethiopia. Journal of BioMed Research and Reports, 2023.

[68] G. Younis et al. PREVALENCE AND VIRULENCE PROFILE OF AVIAN PATHOGENIC E.COLI ISOLATED FROM CLINICALLY DISEASED BROILER CHICKENS. Journal, null.

[69] Roseliza Roslee et al. Antibiotic resistance of Escherichia coli isolated from chicken in Malaysia. Journal, 2016.

[70] S. Nandi et al. HARINGHATA BLACK CHICKEN SHOWS RESISTANCE TO PATHOGENIC E. coli BY HIGH IMMUNE-EFFECTOR ACTIVITIES. Journal, 2016.

[71] Marianna Rodrigues de Souza Campos et al. Clinical and non-clinical Escherichia coli from chickens reveal antimicrobial resistance patterns of one health concern. Comparative Immunology, Microbiology & Infectious Diseases, 2026.

[72] Z. Rajabi, Sima Alempour Rajabi. Cross Immunity of a Sonicated Trivalent Avian Coli-bacillosis Vaccine to Pathogenic Escherichia

Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.